Incidence of end-stage renal disease in patients with type 1 diabetes

Diabetes Care

Volumn 41, Issue 3, 2018, Pages 434-439

  Helve, Jaakko ^a,b   Sund, Reijo ^b,c   Arffman, Martti ^c,d   Harjutsalo, Valma ^b,e   Groop, Per Henrik ^a,b,e,f   Gronhagen Riska, Carola ^a   Finne, Patrik ^a,b  

^a Finnish Registry for Kidney Diseases   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; END STAGE RENAL DISEASE; FEMALE; FINLAND; FOLLOW UP; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEX DIFFERENCE; CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETIC NEPHROPATHY; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FINLAND; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 85042588674     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-2364     Document Type: Article

References (34)

1. Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH. Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study. Kidney Int 2005;68: 1250-1257.
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 1983;25:496-501.
3. Groop PH, Thomas MC, Moran JL, et al.; Finn- Diane Study Group. The presence and severity of chronic kidney disease predicts all-causemortality in type 1 diabetes. Diabetes 2009;58:1651-1658.
4. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: A report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010;53:2312-2319.
5. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994;330:15-18.
6. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26: 1258-1264.
7. Otani T, Yokoyama H, Ohashi Y, Uchigata Y. Improved incidence of end-stage renal disease of type 1 diabetes in Japan, froma hospital-based survey. BMJ Open Diabetes Res Care 2016;4: E000177.
8. Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005;294:1782-1787.
9. Mollsten A, Svensson M, Waernbaum I, et al.; Swedish Childhood Diabetes Study Group; Diabetes Incidence Study in Sweden; Swedish Renal Registry. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: A nationwide population-based cohort study. Diabetes 2010; 59: 1803-1808.
10. Svensson M, Nystrom L, Schon S, Dahlquist G. Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: A nationwide population-based study. Diabetes Care 2006; 29: 538-542.
11. Harjutsalo V, Maric C, Forsblom C, Thorn L, Waden J, Groop PH; FinnDiane Study Group. Sexrelated differences in the long-Term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia 2011;54:1992-1999.
12. Costacou T, Fried L, Ellis D, Orchard TJ. Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: A contemporary analysis. Am J Kidney Dis 2011; 58:565-573.
13. Toppe C, Mollsten A, Schon S, Jonsson A, Dahlquist G. Renal replacement therapy due to type 1 diabetes; time trends during 1995- 2010-A Swedish population based register study. J Diabetes Complications 2014;28:152-155.
14. Sund R, Koski S, Fin DM II. On the registerbased measurement of the prevalence and incidence of diabetes and its long-Termcomplications. A technical report [article online], 2009. Tampere, Finland, Finnish Diabetes Association. Available from http://www.diabetes.fi/files/1167/DehkoFinDM-Raportti-ENG.pdf. Accessed 9 November 2017.
15. Finnish Registry for Kidney Diseases - report 2014 [Internet]. Available from http://www.muma.fi/files/2154/Finnish-Registry-for-Kidney-Diseases-2014.pdf. Accessed 9 November 2017.
16. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, La Porte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 1516-1526.
17. Asao K, Sarti C, Forsen T, et al.; Diabetes Epidemiology Research International Mortality Study Group. Long-Term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 2003;26: 2037-2042.
18. Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study. Kidney Int 1996;50: 2041-2046.
19. Nishimura R, Dorman JS, Bosnyak Z, Tajima N, Becker DJ, Orchard TJ; Diabetes Epidemiology Research International Mortality Study; Allegheny County Registry. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: A report from the Allegheny County Registry. Am J Kidney Dis 2003; 42: 117-124.
20. Assogba FG, Couchoud C, Hannedouche T, et al.; French Renal Epidemiology and Information Network Registry. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia 2014; 57:718-728.
21. Stewart JH, McCredie MR, Williams SM; ESRD Incidence Study Group. Divergent trends in the incidence of end-stage renal disease due to type 1 and type 2 diabetes in Europe, Canada and Australia during 1998-2002. Diabet Med 2006;23:1364-1369.
22. Krolewski AS, Bonventre JV. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline. Semin Nephrol 2012;32:407-414.
23. Rosolowsky ET, Skupien J, Smiles AM, et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 2011;22: 545-553.
24. Bentata Y, Haddiya I, Latrech H, Serraj K, Abouqal R. Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes. Saudi J Kidney Dis Transpl 2013; 24: 392-402.
25. de Boer IH, Afkarian M, Rue TC, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2014;25:2342-2350.
26. de Boer IH, Sun W, Cleary PA, et al.; DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011;365:2366-2376.
27. de Boer IH, Rue TC, Cleary PA, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-Term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 2011; 171: 412-420.
28. Forsblom C, Harjutsalo V, Thorn LM, et al.; FinnDiane Study Group. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011; 22: 537-544.
29. Lecaire TJ, Klein BE, Howard KP, Lee KE, Klein R. Risk for end-stage renal disease over 25 years in the population-based WESDR cohort. Diabetes Care 2014;37:381-388.
30. Raile K, Galler A, Hofer S, et al. Diabetic nephropathy in 27, 805 children, adolescents, and adults with type 1 diabetes: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007;30:2523- 2528.
31. Stadler M, Peric S, Strohner-Kaestenbauer H, et al. Mortality and incidence of renal replacement therapy in people with type 1 diabetes mellitus-A three decade long prospective observational study in the Lainz T1DM cohort. J Clin Endocrinol Metab 2014;99:4523-4530.
32. Marshall SM. Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s? Diabetologia 2012; 55: 2301-2306.
33. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetesmellitus. Diabetologia 1985;28:590-596.
34. Haapio M, Helve J, Groop PH, Gronhagen-Riska C, Finne P. Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007. Diabetes Care 2010;33:1718-1723.